A low-cost and eco-friendly recombinant protein expression system using copper-containing industrial wastewater

Front Microbiol. 2024 Mar 21:15:1367583. doi: 10.3389/fmicb.2024.1367583. eCollection 2024.

Abstract

The development of innovative methods for highly efficient production of recombinant proteins remains a prominent focus of research in the biotechnology field, primarily due to the fact that current commercial protein expression systems rely on expensive chemical inducers, such as isopropyl β-D-thiogalactoside (IPTG). In our study, we designed a novel approach for protein expression by creating a plasmid that responds to copper. This specialized plasmid was engineered through the fusion of a copper-sensing element with an optimized multiple cloning site (MCS) sequence. This MCS sequence can be easily customized by inserting the coding sequences of target recombinant proteins. Once the plasmid was generated, it was introduced into an engineered Escherichia coli strain lacking copA and cueO. With this modified E. coli strain, we demonstrated that the presence of copper ions can efficiently trigger the induction of recombinant protein expression, resulting in the production of active proteins. Most importantly, this expression system can directly utilize copper-containing industrial wastewater as an inducer for protein expression while simultaneously removing copper from the wastewater. Thus, this study provides a low-cost and eco-friendly strategy for the large-scale recombinant protein production. To the best of our knowledge, this is the first report on the induction of recombinant proteins using industrial wastewater.

Keywords: copper-induced; eco-friendly; industrial wastewater; low-cost; protein expression.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Zhejiang Province Public Welfare Technology Application Research Project (LTGS24C010001), the Key Discipline of Zhejiang Province in Medical Technology (First Class, Category A), and the Science and Technology Project of Wenzhou (S20210008, Y20220333).